INO
1.09 USD
+0.97%
Today
+0.00%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Inovio Pharmaceuticals Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
78.07M
Avg Daily Volume
2.75M
52 Week High
2.98 USD
52 Week Low
1.07 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade squamous intraepithelial lesions; INO-3112 for the treatment of HPV-related Oropharyngeal squamous cell carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 2/3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. The company's partners and collaborators ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the University of Pennsylvania, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
Top News
AmAirlines
-0.53%
Coeur
+2.59%
Celldex
-3.82%
ConocoPhil
-0.24%
Chevron
-0.53%
Delta
-0.16%
Devon
+0.23%
EsteeLauder
-0.66%
Freeport_Mcmoran
+2.43%
Hecla.Mining
+0.73%
Inovio
+0.00%
JBHunt
+0.86%
LockheedM
-1.76%
Southwest
-1.74%
NewmontM
+2.35%
NorthropGr
-1.80%
Occidental
+0.00%
Rivian_Automotive
+1.25%
SallyBeauty
-4.19%
SouthernCopper
+2.32%
Sleep.Number
+2.26%
TeslaMotor
+1.03%
UnitedCon
-1.32%
Wingstop
+0.63%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
reuters.com
1w ago
AmAirlines
-0.53%
Coeur
+2.59%
Celldex
-3.82%
ConocoPhil
-0.24%
Chevron
-0.53%
Delta
-0.16%
Devon
+0.23%
EsteeLauder
-0.66%
Freeport_Mcmoran
+2.43%
Hecla.Mining
+0.73%
Inovio
+0.00%
JBHunt
+0.86%
LockheedM
-1.76%
Southwest
-1.74%
NewmontM
+2.35%
NorthropGr
-1.80%
Occidental
+0.00%
SallyBeauty
-4.19%
SouthernCopper
+2.32%
UnitedCon
-1.32%
Wingstop
+0.63%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding
reuters.com
1w ago
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
